Post Job

Illumina CEO and Executives

Executive Summary. Based on our data team's research, Francis A. Desouza is the Illumina's CEO. Illumina has 7,800 employees, of which 51 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Illumina executive team is 35% female and 65% male.
  • 62% of the management team is White.
  • 13% of Illumina management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work At Illumina?
Share Your Experience

Rate Illumina's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Francis A. Desouza

Chief Executive Officer

Francis A. Desouza's LinkedIn

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

John R. Stuelpnagel

Founder

David Walt

Founder

Larry Bock

Founder

Anthony Czarnik

Founder

Mark Chee

Founder

Satnam Alag

Founder

Alexander Aravanis

Chief Technology Officer and Head of Research and Product Development

Alexander Aravanis's LinkedIn

For nearly 20 years Alex has led innovation spanning basic research and technology development to late-stage clinical development. He first joined Illumina in 2013 and led research to create the first distributed comprehensive genomic profiling assay for liquid biopsy and tumor tissue, the first exome-wide targeted RNA assays for tumor tissue, massively parallel single cell sequencing, and other sequencing platform technologies including semiconductor-based detection. In 2016, Alex co-founded and served as Chief Scientific Officer and Head of R&D at GRAIL, where he led teams developing a multi-cancer early detection test by combining high-intensity sequencing, data science and engineering, including powerful machine learning approaches such as neural networks. His team at GRAIL created one of the largest clinical study programs ever in genomic medicine. Alex returned to Illumina in June 2020 as CTO, leading the company’s research and technology development and the innovation engine for next-generation sequencing platforms and applications. Alex is an inventor on numerous patents and publications. He has an MD and a PhD in Electrical Engineering from Stanford University and a BS in Electrical Engineering from UC Berkeley.

Joydeep Goswami Ph.D.

Chief Strategy & Corporate Development Officer

Joydeep Goswami Ph.D.'s LinkedIn

Joydeep Goswami is Chief Strategy and Corporate Development Officer where he responsible for driving planning, strategic partnerships and acquisitions.

Most recently, he served as the President of Thermo Fisher Scientific’s Clinical Next-Generation Sequencing (NGS) and Oncology business unit, where he oversaw efforts that drove the adoption of NGS in clinical oncology, research and reproductive health. Goswami has held senior leadership roles across the pharma/biotech, diagnostics and research tool continuum, previously serving at companies such as Life Technologies and Invitrogen, in addition to Thermo Fisher Scientific. He has led teams across various functions, including sales, marketing, R&D and other support functions. Mr. Goswami served as President, Asia Pacific and Japan while at Thermo Fisher Scientific and created the Stem Cells and Regenerative Medicine Business Unit at Invitrogen. Additionally, he spent five years at McKinsey, where he specialized in strategy for pharmaceutical, medical technology and technology companies.

Mr. Goswami holds his MS, PhD in Chemical Engineering, an MBA from MIT and a Bachelor’s degree in Chemical Engineering from the Indian Institute of Technology.

Susan H. Tousi

Senior Vice President

Susan H. Tousi's LinkedIn

Susan Tousi is Chief Commercial Officer at Illumina, where she is leads global sales, commercial operations, and commercial strategy and enablement. Susan combines her extensive general management leadership and deep technical knowledge of Illumina’s product portfolio to ensure the global commercial success of the organization. She is committed to empowering Illumina customers with innovations to further unlock the power of the genome.

Susan has been with Illumina since 2012, and previously lead the product development organization as Chief Product Officer. During that time, she was responsible for global engineering, consumables, sequencing applications, IVD, software and informatics development efforts: During this time, she oversaw the most impactful decade of product launches including: HiSeq X, NovaSeq, MiSeq Dx, NextSeq 550Dx/1000/2000, iSeq, VeriSeq NIPT, TSO500, COVIDSeq, DRAGEN™, and Illumina Connected Analytics. Additionally, she led the acquisition of Edico Genomics, BlueBee, and Enancio, combined with Illumina’s existing software solutions, these new capabilities enable scalable, seamless, end-to-end software solutions that drive the utilization of genomic data and accelerate the adoption of genomic data in clinical care.

Susan has more than 25 years of R&D and business leadership at Fortune 100 technology companies and within the life sciences industry. Formerly, she was Corporate Vice President and General Manager for Eastman Kodak’s Consumer Inkjet Systems organization. Prior to joining Kodak, Susan was an R&D program manager for Phogenix Imaging LLC, a joint venture start-up of Hewlett-Packard and Kodak. She previously spent 10 years with Hewlett-Packard in technical and management roles. Along with many academic honors, she has received numerous awards in both business and technology. In 2018, Susan was elected to the National Academy of Engineers. Susan was named one of the 50 Top Diverse Leaders for 2020 by the California Diversity Council and is a member of the International Women’s Forum, a global organization of preeminent women of significant and diverse achievement.

Susan holds an MBA degree from UCLA and an Honors BS in Engineering Science and Mechanics from Pennsylvania State University.

Susan serves as an executive trustee at the world renowned La Jolla Playhouse and on the UCSD Jacobs School of Engineering Dean’s Council of Advisors.

Do you work at Illumina?

Does leadership effectively guide Illumina toward its goals?

Illumina Jobs

Illumina Founders

Name & TitleBio
John R. Stuelpnagel

Founder

David Walt

Founder

Larry Bock

Founder

Anthony Czarnik

Founder

Mark Chee

Founder

Satnam Alag

Founder

Illumina Board Members

Name & TitleBio
Francis A. Desouza

Chief Executive Officer

Francis A. Desouza's LinkedIn

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

John Wendell Thompson

Board Chair

Frances Hamilton Arnold

Board Member

Philip W. Schiller

Board Member

Susan E. Siegel

Board Member

Caroline D. Dorsa

Board Member

Gary S. Guthart

Board Member

Robert S. Epstein

Board Member

Scott Gottlieb

Board Member

Dan Bradbury

Board Member

Illumina Leadership Demographics

Illumina Gender Distribution in Management Team

  • The Illumina executive team is 35% female and 65% male.
  • Illumina is 38% female and 62% male company-wide.
Male
Male
65%
Company-wide: 62%
Female
Female
35%
Company-wide: 38%

Illumina Executives by Race

Management Team:
  • The most common ethnicity among Illumina executive officers is White.
  • 62% of the management team is White.
  • 13% of Illumina's management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 46% of employees are White.
  • 23% of employees are Hispanic or Latino.
  • 20% of employees are Asian.
  • Management Team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Illumina Jobs Nearby

Illumina Executives FAQs

Zippia gives an in-depth look into the details of Illumina, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Illumina. The employee data is based on information from people who have self-reported their past or current employments at Illumina. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Illumina. The data presented on this page does not represent the view of Illumina and its employees or that of Zippia.

Illumina may also be known as or be related to Illumina, Illumina Inc and Illumina, Inc.